Alkermes plc Stock
Price
Target price
?
?
0.830%
0.2
0.830%
€38.37
08:47 / Stuttgart Stock Exchange
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Alkermes plc Stock
Alkermes plc gained 0.830% compared to yesterday.
Alkermes plc is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 38 € shows a very positive potential of 57.02% compared to the current price of 24.2 € for Alkermes plc.
Pros and Cons of Alkermes plc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 0.830% | -2.439% | -13.669% | -22.078% | 1.695% | -3.942% | 48.148% |
| Icon plc | 1.610% | -6.970% | 9.951% | -49.301% | -44.524% | -56.586% | - |
| Iovance Biotherapeutics Inc. | 1.050% | -21.720% | 59.719% | 5.595% | 46.016% | -46.177% | -88.167% |
| United Therapeutics | 1.450% | 13.960% | 17.057% | 66.336% | 9.853% | 128.307% | 247.704% |
Comments
Alkermes (ALKS) had its price target lowered by Royal Bank Of Canada from $47.00 to $45.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (ALKS) had its price target raised by Wells Fargo & Company from $37.00 to $43.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Truist Financial Corporation from $50.00 to $55.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat